Breaking News Headlines Today

News from Pharmaphorum

See all of Pharmaphorum news coverage in one place. Discover how Pharmaphorum’s media bias informs their coverage and compare with thousands of other news outlets.

We’ve aggregated 423 of Pharmaphorum’s headlines and news stories over the past 3 months.

The Ground News media bias check for Pharmaphorum is Center. Scores are assigned by aggregating bias scores from Ad Fontes Media, Media Bias/Fact Check, and All Sides.

If you want to know if Pharmaphorum is credible or reliable, look no further. We rank Pharmaphorum as High factuality. Find out more about our methodology here.

Information about Pharmaphorum

Where is Pharmaphorum located?Pharmaphorum's Website

Media Bias Ratings

Average Bias Rating:

Center

byAd Fontes Media

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Pharmaphorum News

World Health Organization

WHO Endorses Twice-Yearly Lenacapavir Injections for HIV Prevention

79% Center coverage: 43 sources

See the Story

US Politics · United States

HHS Carries Out Mass Firings Across Health Agencies After Supreme Court Decision

81% Center coverage: 32 sources

See the Story

Wegovy · China

AstraZeneca Blockbuster Prospect Is a Bust in Pivotal Test in Light Chain Amyloidosis

100% Center coverage: 3 sources

Though anselamimab failed its Phase 3 test in light chain amyloidosis, AstraZeneca points to encouraging results in a pre-defined patient subgroup — which may not be a winning strategy. Prothena resurrected its failed drug candidate for the disease based on a subgroup analysis, only to see that antibody fall short in a pivotal study. The post AstraZeneca Blockbuster Prospect Is a Bust in Pivotal Test in Light Chain Amyloidosis appeared first on …See the Story

Medicine’s blind spot: How clinical trials are failing women

100% Center coverage: 1 sources

One glaring issue continues to undermine clinical research: the persistent under-representation of women in trials.Medical Read Article

Integrating movement into the care of patients living with bipolar I disorder

100% Center coverage: 1 sources

For people living with serious mental illnesses, such as BD-I, engaging in sports (or any kind of exercise) can contribute to not just physical health, but also cognitive and emotional well-being.Health Read Article

How This New Biotech Billionaire Outmaneuvered Merck In China

75% Center coverage: 4 sources

Michelle Xia gained experience at U.S. pharmaceutical firms before launching her own biotech company back home in China. In a trial last year, the firm’s cancer drug outperformed the world’s best seller–and its surging stock just made her a billionaire.Merck · China See the Story

News from Pharmaphorum

News from Pharmaphorum

Information about Pharmaphorum

Media Bias Ratings

Factuality

Ownership

Top Pharmaphorum News

WHO Endorses Twice-Yearly Lenacapavir Injections for HIV Prevention

HHS Carries Out Mass Firings Across Health Agencies After Supreme Court Decision

Cost of Obesity Drugs Drops but Barriers to Access Remain

UK Biobank Completes World's Largest 100,000-Volunteer Whole-Body Imaging Study

Takeda Stock Rises After Positive Phase 3 Results for Narcolepsy Drug

From Pilots to Impact: What It Really Takes to Scale GenAI in Pharma

FDA fast-tracks Sanofi's gene therapy for eye disease GA

AstraZeneca Blockbuster Prospect Is a Bust in Pivotal Test in Light Chain Amyloidosis

Medicine’s blind spot: How clinical trials are failing women

Integrating movement into the care of patients living with bipolar I disorder

How This New Biotech Billionaire Outmaneuvered Merck In China

Similar News Topics

Topics Most Covered by Pharmaphorum

Sources Covering Similar Topics

Breaking News Topics Related to Pharmaphorum